| 1.28 0.03 (2.4%) | 10-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.13 | 1-year : | 2.58 |
| Resists | First : | 1.82 | Second : | 2.21 |
| Pivot price | 1.62  |
|||
| Supports | First : | 1.2 | Second : | 0.99 |
| MAs | MA(5) : | 1.26 |
MA(20) : | 1.58 |
| MA(100) : | 1.16  |
MA(250) : | 1 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 5.2 |
D(3) : | 4.8 |
| RSI | RSI(14): 42.4 |
|||
| 52-week | High : | 2.21 | Low : | 0.53 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HYPR ] has closed above bottom band by 25.3%. Bollinger Bands are 234% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.32 - 1.33 | 1.33 - 1.33 |
| Low: | 1.24 - 1.25 | 1.25 - 1.25 |
| Close: | 1.27 - 1.28 | 1.28 - 1.29 |
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
Wed, 15 Oct 2025
Hyperfine Announces Proposed Public Offering - Business Wire
Tue, 07 Oct 2025
Hyperfine, Inc. (NASDAQ:HYPR) Looks Just Right With A 30% Price Jump - simplywall.st
Mon, 06 Oct 2025
Hyperfine launches PULSE platform for portable MRI researchers - Investing.com
Mon, 06 Oct 2025
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI - Stock Titan
Mon, 18 Aug 2025
Hyperfine (HYPR) Upgraded to Buy: Here's Why - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 64 (M) |
| Shares Float | 59 (M) |
| Held by Insiders | 6.6 (%) |
| Held by Institutions | 14.2 (%) |
| Shares Short | 1,840 (K) |
| Shares Short P.Month | 2,040 (K) |
| EPS | -0.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.44 |
| Profit Margin | 0 % |
| Operating Margin | -355.9 % |
| Return on Assets (ttm) | -43.4 % |
| Return on Equity (ttm) | -77.3 % |
| Qtrly Rev. Growth | -25.8 % |
| Gross Profit (p.s.) | 0.07 |
| Sales Per Share | 0.16 |
| EBITDA (p.s.) | -0.65 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -34 (M) |
| Levered Free Cash Flow | -21 (M) |
| PE Ratio | -2.47 |
| PEG Ratio | 0 |
| Price to Book value | 2.84 |
| Price to Sales | 7.52 |
| Price to Cash Flow | -2.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|